Xeris Pharmaceuticals Inc
(XERS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XERS | SVRA | TBPH | ||
| Company | Xeris Pharmaceuticals Inc | Savara Inc | Theravance Bio Ord | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.94 | 5.84 | 19.49 | ||
| High | 7.10 | 6.06 | 19.93 | ||
| Low | 6.80 | 5.57 | 19.32 | ||
| Latest | 6.82 | 5.60 | 19.53 | ||
| Change | -0.09 | -0.23 | +0.13 | ||
| % Change | -1.30% | -3.95% | +0.67% | ||
| Volume | 985,400 | 1,452,900 | 394,900 | ||
| 20-Day Average Volume | 1,375,965 | 1,454,760 | 376,270 | ||
| Previous Close | 6.91 | 5.83 | 19.40 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.25 | 5.65 | 19.79 | ||
| 20-Day Raw Stochastic | 3.74% | 36.20% | 41.86% | ||
| 20-Day Relative Strength | 42.07 | 49.40 | 52.03 | ||
| Weighted Alpha | +64.77 | +96.38 | +106.15 | ||
| Today's Opinion | 32% Sell | 40% Buy | 88% Buy | ||
| Previous Opinion | 16% Sell | 56% Buy | 88% Buy | ||
| Last Month's Opinion | 56% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.71% since 02/06/26 | +5.66% since 02/06/26 | -4.64% since 02/06/26 | ||
| Low | 6.78 on 02/12/26 | 5.09 on 02/11/26 | 18.45 on 02/11/26 | ||
| High | 7.26 on 02/11/26 | 6.06 on 02/13/26 | 20.60 on 02/09/26 | ||
| 1-Month | |||||
| %Chg | -11.54% since 01/13/26 | -5.41% since 01/13/26 | -3.94% since 01/13/26 | ||
| Low | 6.78 on 02/12/26 | 5.09 on 02/11/26 | 18.45 on 02/11/26 | ||
| High | 7.85 on 01/22/26 | 6.49 on 01/22/26 | 21.03 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | -6.06% since 11/13/25 | +31.46% since 11/13/25 | +8.80% since 11/13/25 | ||
| Low | 6.47 on 12/05/25 | 4.14 on 11/18/25 | 16.82 on 11/14/25 | ||
| High | 8.42 on 01/08/26 | 7.01 on 12/12/25 | 21.03 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | -6.32% since 08/13/25 | +107.41% since 08/13/25 | +57.25% since 08/13/25 | ||
| Low | 6.47 on 12/05/25 | 2.68 on 08/14/25 | 12.27 on 08/14/25 | ||
| High | 10.08 on 11/05/25 | 7.01 on 12/12/25 | 21.03 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,131,602 | 1,139,421 | 989,624 | ||
| Shares Outstanding, K | 165,924 | 203,468 | 50,672 | ||
| Annual Sales | 203,070,000 | 0 | 64,380,000 | ||
| Annual Net Income | -54,840,000 | -95,880,000 | -56,420,000 | ||
| Last Quarter Sales | 74,380,000 | 0 | 19,990,000 | ||
| Last Quarter Net Income | 620,000 | -29,560,000 | 3,620,000 | ||
| 60-Month Beta | 0.52 | 0.34 | 0.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 11/06/25 | -0.14 on 11/12/25 | 0.04 on 11/10/25 | ||
| Latest Earnings Date | 03/02/26 | 03/26/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 41.28 | ||